The authors showed that cisplatin treatment induced the expression and nuclear translocation of FOXO1 and FOXO3a in NSCLC cells, making them susceptible to cisplatin-mediated apoptosis. The gene discussed is FOXO1; the disease is non-small cell lung carcinoma.